Literature DB >> 2254320

TE671 cells express an abundance of a partially mature acetylcholine receptor alpha subunit which has characteristics of an assembly intermediate.

W G Conroy1, M S Saedi, J Lindstrom.   

Abstract

A partially mature form of the nicotinic acetylcholine receptor alpha subunit was found to be expressed in the human cell line TE671. We found that 40-50% of the alpha-bungarotoxin-binding sites in detergent extracts of these cells corresponds to this unassembled alpha subunit. These unassembled alpha subunits are not found in the surface membrane. The unassembled alpha subunits in extracts from TE671 cells appear, like mature receptors, to have a disulfide bond between Cys-192 and Cys-193 near the acetylcholine-binding site. The unassembled alpha subunit binds alpha-bungarotoxin with high affinity, but its dissociation constant is still 5-fold higher than the native assembled acetylcholine receptor. The cholinergic ligands d-tubocurarine and carbamylcholine have negligible affinity for the immature alpha subunit. Similarly, Xenopus oocytes injected with RNA transcripts for the TE671 alpha subunit express an alpha-bungarotoxin-binding component which is insensitive to carbamylcholine and has a sedimentation coefficient on sucrose gradients of 5.0 S. Oocytes injected with RNA for the Torpedo alpha subunit did not have alpha-bungarotoxin binding activity under similar conditions, suggesting a possible differential efficiency in the maturation of this alpha subunit. We examined the binding of monoclonal antibodies specific to the main immunogenic region and found that this epitope on the unassembled alpha subunit was formed, but was not in a fully mature conformation because although these antibodies bound, they bound with lower affinity than to native acetylcholine receptors. Antibodies in myasthenia gravis patient sera also bound to the unassembled alpha subunits, but with an average 14-fold lower titer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254320

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors.

Authors:  Jie Luo; Jon Lindstrom
Journal:  Autoimmunity       Date:  2011-10-21       Impact factor: 2.815

2.  Detection of antibodies directed against the cytoplasmic region of the human acetylcholine receptor in sera from myasthenia gravis patients.

Authors:  S J Tzartos; M Remoundos
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 3.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

4.  Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity.

Authors:  Jie Luo; Palmer Taylor; Mario Losen; Marc H de Baets; G Diane Shelton; Jon Lindstrom
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

5.  Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection.

Authors:  Feng Lin; Henry J Kaminski; Bianca M Conti-Fine; Wei Wang; Chelliah Richmonds; M Edward Medof
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  Development of an assay for modulating anti-acetylcholine receptor autoantibodies using human rhabdomyosarcoma cell line.

Authors:  B W Lyons; L L Wu; M E Astill; J T Wu
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

7.  Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss.

Authors:  T Guyon; A Wakkach; S Poea; V Mouly; I Klingel-Schmitt; P Levasseur; D Beeson; O Asher; S Tzartos; S Berrih-Aknin
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

8.  Assembly of Torpedo acetylcholine receptors in Xenopus oocytes.

Authors:  M S Saedi; W G Conroy; J Lindstrom
Journal:  J Cell Biol       Date:  1991-03       Impact factor: 10.539

9.  Structural insights into the molecular mechanisms of myasthenia gravis and their therapeutic implications.

Authors:  Kaori Noridomi; Go Watanabe; Melissa N Hansen; Gye Won Han; Lin Chen
Journal:  Elife       Date:  2017-04-25       Impact factor: 8.140

10.  Chemical Synthesis of a Functional Fluorescent-Tagged α-Bungarotoxin.

Authors:  Oliver Brun; Claude Zoukimian; Barbara Oliveira-Mendes; Jérôme Montnach; Benjamin Lauzier; Michel Ronjat; Rémy Béroud; Frédéric Lesage; Didier Boturyn; Michel De Waard
Journal:  Toxins (Basel)       Date:  2022-01-21       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.